These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 10772829)
1. Cell cycle arrest by the PTEN tumor suppressor is target cell specific and may require protein phosphatase activity. Hlobilkova A; Guldberg P; Thullberg M; Zeuthen J; Lukas J; Bartek J Exp Cell Res; 2000 May; 256(2):571-7. PubMed ID: 10772829 [TBL] [Abstract][Full Text] [Related]
2. PTEN coordinates G(1) arrest by down-regulating cyclin D1 via its protein phosphatase activity and up-regulating p27 via its lipid phosphatase activity in a breast cancer model. Weng LP; Brown JL; Eng C Hum Mol Genet; 2001 Mar; 10(6):599-604. PubMed ID: 11230179 [TBL] [Abstract][Full Text] [Related]
3. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death. Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703 [TBL] [Abstract][Full Text] [Related]
4. PTEN can inhibit in vitro organotypic and in vivo orthotopic invasion of human bladder cancer cells even in the absence of its lipid phosphatase activity. Gildea JJ; Herlevsen M; Harding MA; Gulding KM; Moskaluk CA; Frierson HF; Theodorescu D Oncogene; 2004 Sep; 23(40):6788-97. PubMed ID: 15273733 [TBL] [Abstract][Full Text] [Related]
5. Proteome profile changes that are differentially regulated by lipid and protein phosphatase activities of tumor suppressor PTEN in PTEN-expressing U-87 MG human glioblastoma cells. Shim JH; Kim YS; Bahk YY Proteomics; 2006 Jan; 6(1):81-93. PubMed ID: 16294307 [TBL] [Abstract][Full Text] [Related]
6. Nuclear PTEN-mediated growth suppression is independent of Akt down-regulation. Liu JL; Sheng X; Hortobagyi ZK; Mao Z; Gallick GE; Yung WK Mol Cell Biol; 2005 Jul; 25(14):6211-24. PubMed ID: 15988030 [TBL] [Abstract][Full Text] [Related]
7. Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Weng LP; Gimm O; Kum JB; Smith WM; Zhou XP; Wynford-Thomas D; Leone G; Eng C Hum Mol Genet; 2001 Feb; 10(3):251-8. PubMed ID: 11159944 [TBL] [Abstract][Full Text] [Related]
8. PTEN suppresses hyaluronic acid-induced matrix metalloproteinase-9 expression in U87MG glioblastoma cells through focal adhesion kinase dephosphorylation. Park MJ; Kim MS; Park IC; Kang HS; Yoo H; Park SH; Rhee CH; Hong SI; Lee SH Cancer Res; 2002 Nov; 62(21):6318-22. PubMed ID: 12414663 [TBL] [Abstract][Full Text] [Related]
9. Regulation of cell migration by the C2 domain of the tumor suppressor PTEN. Raftopoulou M; Etienne-Manneville S; Self A; Nicholls S; Hall A Science; 2004 Feb; 303(5661):1179-81. PubMed ID: 14976311 [TBL] [Abstract][Full Text] [Related]
10. Growth-suppressive effects of BPOZ and EGR2, two genes involved in the PTEN signaling pathway. Unoki M; Nakamura Y Oncogene; 2001 Jul; 20(33):4457-65. PubMed ID: 11494141 [TBL] [Abstract][Full Text] [Related]
11. [PTEN: a tumor suppressor with original properties]. Roux P Bull Cancer; 1999 Jun; 86(6):522-5. PubMed ID: 10417424 [TBL] [Abstract][Full Text] [Related]
12. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Furnari FB; Huang HJ; Cavenee WK Cancer Res; 1998 Nov; 58(22):5002-8. PubMed ID: 9823298 [TBL] [Abstract][Full Text] [Related]
13. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Paramio JM; Navarro M; Segrelles C; Gómez-Casero E; Jorcano JL Oncogene; 1999 Dec; 18(52):7462-8. PubMed ID: 10602505 [TBL] [Abstract][Full Text] [Related]
14. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Myers MP; Pass I; Batty IH; Van der Kaay J; Stolarov JP; Hemmings BA; Wigler MH; Downes CP; Tonks NK Proc Natl Acad Sci U S A; 1998 Nov; 95(23):13513-8. PubMed ID: 9811831 [TBL] [Abstract][Full Text] [Related]
15. The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells. Lu Y; Lin YZ; LaPushin R; Cuevas B; Fang X; Yu SX; Davies MA; Khan H; Furui T; Mao M; Zinner R; Hung MC; Steck P; Siminovitch K; Mills GB Oncogene; 1999 Nov; 18(50):7034-45. PubMed ID: 10597304 [TBL] [Abstract][Full Text] [Related]
16. PTEN regulatory functions in tumor suppression and cell biology. Chu EC; Tarnawski AS Med Sci Monit; 2004 Oct; 10(10):RA235-41. PubMed ID: 15448614 [TBL] [Abstract][Full Text] [Related]
17. MMAC1/PTEN inhibits cell growth and induces chemosensitivity to doxorubicin in human bladder cancer cells. Tanaka M; Koul D; Davies MA; Liebert M; Steck PA; Grossman HB Oncogene; 2000 Nov; 19(47):5406-12. PubMed ID: 11103942 [TBL] [Abstract][Full Text] [Related]
18. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1. Bruni P; Boccia A; Baldassarre G; Trapasso F; Santoro M; Chiappetta G; Fusco A; Viglietto G Oncogene; 2000 Jun; 19(28):3146-55. PubMed ID: 10918569 [TBL] [Abstract][Full Text] [Related]
19. PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis. Wick W; Furnari FB; Naumann U; Cavenee WK; Weller M Oncogene; 1999 Jul; 18(27):3936-43. PubMed ID: 10435616 [TBL] [Abstract][Full Text] [Related]
20. Thioredoxin-1 binds to the C2 domain of PTEN inhibiting PTEN's lipid phosphatase activity and membrane binding: a mechanism for the functional loss of PTEN's tumor suppressor activity. Meuillet EJ; Mahadevan D; Berggren M; Coon A; Powis G Arch Biochem Biophys; 2004 Sep; 429(2):123-33. PubMed ID: 15313215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]